BCLS ACQUISITION CORP's ticker is BLSA and the CUSIP is G0904B105. A total of 47 filers reported holding BCLS ACQUISITION CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $4,885,000 | +1.2% | 487,500 | 0.0% | 0.58% | +3.0% |
Q2 2022 | $4,826,000 | +0.3% | 487,500 | 0.0% | 0.57% | +21.2% |
Q1 2022 | $4,812,000 | +0.7% | 487,500 | 0.0% | 0.47% | +23.2% |
Q4 2021 | $4,778,000 | -1.6% | 487,500 | 0.0% | 0.38% | +25.9% |
Q3 2021 | $4,856,000 | -5.4% | 487,500 | 0.0% | 0.30% | -10.4% |
Q2 2021 | $5,133,000 | -0.4% | 487,500 | 0.0% | 0.34% | +15.1% |
Q1 2021 | $5,153,000 | -5.1% | 487,500 | 0.0% | 0.29% | -14.4% |
Q4 2020 | $5,431,000 | – | 487,500 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 842,500 | $9,385,000 | 2.55% |
COMMODORE CAPITAL LP | 250,000 | $2,785,000 | 1.51% |
SPHERA FUNDS MANAGEMENT LTD. | 625,000 | $6,891,000 | 0.61% |
First Trust Capital Management L.P. | 184,600 | $2,056,000 | 0.58% |
Asymmetry Capital Management, L.P. | 89,135 | $993,000 | 0.45% |
Altium Capital Management LP | 100,000 | $1,114,000 | 0.42% |
Bain Capital Life Sciences Investors, LLC | 487,500 | $5,431,000 | 0.34% |
Samsara BioCapital, LLC | 300,000 | $3,342,000 | 0.34% |
LH Capital Markets, LLC | 243,387 | $2,711,000 | 0.22% |
RA Capital Management | 1,250,000 | $13,925,000 | 0.20% |